Advances in Neoadjuvant Immunotherapy for NSCLC: Conference Highlights 2023
Dr. Eduardo Santos, MD, FACP, FCCP, highlights advancements in neoadjuvant immunotherapy for NSCLC presented during key conferences in 2023, underscoring pivotal findings and the potential transformation of treatment approaches.
EP: 1.Immunotherapy-Based Strategies for NSCLC in the Neoadjuvant/Perioperative Setting
Now Viewing
EP: 2.Advances in Neoadjuvant Immunotherapy for NSCLC: Conference Highlights 2023
EP: 3.Updates in Adjuvant Immunotherapy for NSCLC: Conference Highlights 2023
EP: 4.Immunotherapy-Based Treatment Strategies in Advanced NSCLC
EP: 5.EMPOWER-Lung3: Evaluating Cemiplimab Plus Chemotherapy in Advanced NSCLC
EP: 6.Advancements in Squamous NSCLC Treatment: Subgroup Analysis from EMPOWER-Lung Trials
EP: 7.Advances in Dual Immunotherapy Approaches for NSCLC: Data Highlights 2023
EP: 8.NSCLC 2023 Data Updates: Shaping the Future Treatment Landscape
Related Videos
Related Content
